PT-141

$29.99

FOR RESEARCH USE ONLY

This product is intended strictly for laboratory research. It is not a drug, food, or supplement, and is not for human or veterinary use.

Fast shipping

Orders processed and shipped within 24 hours with full tracking.

100% safe payments

All transactions are secured with industry-standard encryption.

Premium research grade

Every compound undergoes extensive third-party testing for guaranteed quality.

Independently verified

Every batch is screened by independent labs, so purity is never left to chance.

24/7 support

Our in-house research experts are available to guide you with any questions.

Our promise to you

We stand behind every product, so you can buy with confidence.

Catalog

Featured research compounds

Product description

PT-141

Overview

PT-141 is a synthetic peptide analog studied in laboratory environments for its interaction with the melanocortin receptor system.

In controlled research settings, PT-141 is utilized to examine receptor binding dynamics and peptide-driven signaling pathways at the cellular level.

Scientific Background

PT-141 is a cyclic peptide derived from melanocortin research and is structurally related to alpha-melanocyte–stimulating hormone (α-MSH).

In vitro studies focus on its affinity for melanocortin receptors, receptor selectivity, and signaling behavior. Its cyclic structure contributes to enhanced stability, making it a useful compound for receptor-based signaling models and neurochemical pathway investigations.

Specifications

  • Molecular Formula: C50H68N14O10
  • Sequence: Cyclic melanocortin receptor agonist analog
  • Purity: ≥99%
  • Form: Lyophilized powder
  • Storage: -20°C
  • Solubility: Sterile water or bacteriostatic water

Disclaimer

For laboratory research use only. Not for human consumption, medical use, or veterinary use.

Bourbon Peptides — Research Grade Purity.

bp logo.png

Are you 18 or older?

All products on this site are supplied strictly for laboratory research use. You must confirm you are of legal age and a qualified researcher to continue.

By entering you agree to our Terms and Privacy Policy.